US Stock MarketDetailed Quotes
BGLC BioNexus Gene Lab
- 0.250
- -0.041-14.15%
Close Nov 25 16:00 ET
- 0.245
- -0.005-2.04%
Post 18:30 ET
4.49MMarket Cap20.83P/E (TTM)
0.310High0.247Low218.56KVolume0.299Open0.291Pre Close58.16KTurnover1.59%Turnover RatioLossP/E (Static)17.97MShares3.39052wk High0.48P/B3.44MFloat Cap0.24752wk Low--Dividend TTM13.78MShs Float9.490Historical High--Div YieldTTM21.81%Amplitude0.247Historical Low0.266Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
BioNexus Gene Lab Stock Forum
Dow Jones· 2 mins ago
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
KUALA LUMPUR, Malaysia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- MRNA Scientific Sdn. Bhd. ("MRNA"), a subsidiary of BioNexus Gene Lab Corp. (Nasdaq: BGLC, the "Company"), and Protech Builders Sdn...
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
KUALA LUMPUR, Malaysia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp.(NASDAQ:BGLC, the "Company"))), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce that its wholly owned subsidiary, MRNA Scientific Sdn. Bhd. ("MRNA Scientific"), has entered into a strategic outsourcing agreement with VITARRAY Global Pte. L...
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
BioNexus Gene Lab Corp. (Nasdaq: BGLC) has signed a strategic partnership MOU with Shenzhen Rongguang Health Group to advance cancer screening, precision medicine, and preventative healthcare solutions. The collaboration, led by BGLC's subsidiary MRNA Scientific Sdn Bhd, aims to:
Expand cancer...
No comment yet